97 related articles for article (PubMed ID: 1303319)
1. [Evaluation of long-term efficacy on plasma-derived hepatitis B vaccine].
Xu H
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Dec; 13(6):362-5. PubMed ID: 1303319
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation on efficacy of plasma-derived hepatitis B vaccine and persistence of protective level after vaccination].
Wang S; Wu C; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun; 15(3):154-7. PubMed ID: 7834691
[TBL] [Abstract][Full Text] [Related]
3. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
[TBL] [Abstract][Full Text] [Related]
4. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
Xu H; Zuo H; Zhuang G
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
[TBL] [Abstract][Full Text] [Related]
6. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
Li H; Li R; Liao S; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
[TBL] [Abstract][Full Text] [Related]
7. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
8. [Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children--a 12-year follow-up].
Liao S; Li R; Li H; Yang J; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Apr; 20(2):89-94. PubMed ID: 11367725
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis B virus vaccine: early and late response in Chileans with high risk of infection].
Hurtado C; Brahm J; Chesta J; Latorre R; Velasco M
Rev Med Chil; 1993 May; 121(5):503-5. PubMed ID: 8272630
[TBL] [Abstract][Full Text] [Related]
10. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
[TBL] [Abstract][Full Text] [Related]
11. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
[TBL] [Abstract][Full Text] [Related]
13. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
14. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up of immune response to hepatitis B vaccine in juveniles.
Zhang MT; Liu KZ; Jin JH; Ding LM; Zhou SC; Yu QY; Zhang XZ
Chin Med J (Engl); 1993 Feb; 106(2):97-9. PubMed ID: 8504700
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
Halota W; Muszyńska M; Pawłowska M
Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
[TBL] [Abstract][Full Text] [Related]
17. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and immune memory of plasma-derived hepatitis B vaccine 11 years after primary immunization].
Xu H; Zhuang G; Wang X; Chen Q; Chen Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Mar; 34(2):113-5. PubMed ID: 11860915
[TBL] [Abstract][Full Text] [Related]
20. [A study on the relationship between maximal titers of anti-HBs antibodies and persistence of protective level after vaccination].
Li SQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun; 13(3):134-7. PubMed ID: 1423534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
